pubmed-article:21482348 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21482348 | lifeskim:mentions | umls-concept:C0010337 | lld:lifeskim |
pubmed-article:21482348 | lifeskim:mentions | umls-concept:C0040038 | lld:lifeskim |
pubmed-article:21482348 | lifeskim:mentions | umls-concept:C1507394 | lld:lifeskim |
pubmed-article:21482348 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
pubmed-article:21482348 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:21482348 | lifeskim:mentions | umls-concept:C1301732 | lld:lifeskim |
pubmed-article:21482348 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:21482348 | pubmed:dateCreated | 2011-4-12 | lld:pubmed |
pubmed-article:21482348 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482348 | pubmed:abstractText | This article reports the preparatory studies as well as the design, implementation, and a priori analysis plans of PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) before dissemination of results. PROphylaxis for ThromboEmbolism in Critical Care Trial (NCT00182143) is a randomized, stratified, concealed international trial comparing subcutaneous injection of unfractionated heparin (UFH) 5000 IU or the low-molecular weight heparin (LMWH) dalteparin 5000 IU once daily plus once-daily placebo for the duration of the intensive care unit stay. | lld:pubmed |
pubmed-article:21482348 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482348 | pubmed:language | eng | lld:pubmed |
pubmed-article:21482348 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482348 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21482348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482348 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21482348 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21482348 | pubmed:month | Apr | lld:pubmed |
pubmed-article:21482348 | pubmed:issn | 1557-8615 | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:GuyattGordonG | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:MeadeMaureenM | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:CookDeborahD | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:WalterStephen... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:GeertsWilliam... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:WarkentinTheo... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:ZytarukNicole... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:CrowtherMarkM | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:RochaMarceloM | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:Heels-Ansdell... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:CooperD... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:QushmaqIsmael... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:VallanceShirl... | lld:pubmed |
pubmed-article:21482348 | pubmed:author | pubmed-author:BerwangerOtav... | lld:pubmed |
pubmed-article:21482348 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:21482348 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21482348 | pubmed:volume | 26 | lld:pubmed |
pubmed-article:21482348 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21482348 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21482348 | pubmed:pagination | 223.e1-9 | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:meshHeading | pubmed-meshheading:21482348... | lld:pubmed |
pubmed-article:21482348 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21482348 | pubmed:articleTitle | PROphylaxis for ThromboEmbolism in Critical Care Trial protocol and analysis plan. | lld:pubmed |
pubmed-article:21482348 | pubmed:affiliation | Department of Medicine, McMaster University, Hamilton, Ontario, Canada L8N 3Z5. debcook@mcmaster.ca | lld:pubmed |
pubmed-article:21482348 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21482348 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |